Håkan Mellstedt

5PUBLICATIONS
11CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 28, 2023
A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells.

Amineh Ghaderi, Mohammad-Ali Okhovat, Jemina Lehto

|Jun 02, 2018
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.

Amir Hossein Daneshmanesh, Mohammad Hojjat-Farsangi, Amineh Ghaderi

|Mar 24, 2018
Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients.

Marzia Palma, Lotta Hansson, Tom A Mulder

|Feb 13, 2018
Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.

Parviz Kokhaei, Mohammad Hojjat-Farsangi, Fariba Mozaffari

|Jul 06, 2017
Dual targeting of Bruton tyrosine kinase and CD52 induces minimal residual disease-negativity in the bone marrow of poor-prognosis chronic lymphocytic leukaemia patients but is associated with opportunistic infections - Results from a phase I study.

Maria Winqvist, Marzia Palma, Kia Heimersson

Pageof 1

Frequent Collaborators

1 joint publications

Maria Winqvist

1 joint publications

Marzia Palma

1 joint publications

Lotta Hansson

1 joint publications

Tom A Mulder